{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:41:56Z","timestamp":1778629316693,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,11]]},"DOI":"10.7759\/cureus.37431","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:13:08Z","timestamp":1681211588000},"source":"Crossref","is-referenced-by-count":3,"title":["Complete Regression of an 8-cm Desmoid Fibromatosis After Treatment With Tamoxifen"],"prefix":"10.7759","author":[{"given":"Ryosuke","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumori","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01026-w","article-title":"Desmoid fibromatosis: management in an era of increasing options","volume":"23","author":"Ratan R","year":"2021","unstructured":"Ratan R, Roland CL, Bishop AJ. Desmoid fibromatosis: management in an era of increasing options. Curr Oncol Rep. 2021, 23:41. 10.1007\/s11912-021-01026-w","journal-title":"Curr Oncol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.5489","article-title":"Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation","volume":"29","author":"Salas S","year":"2011","unstructured":"Salas S, Dufresne A, Bui B, et al.. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011, 29:3553-8. 10.1200\/JCO.2010.33.5489","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG)","volume":"28","author":"Kasper B","year":"2017","unstructured":"Kasper B, Baumgarten C, Garcia J, et al.. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017, 28:2399-408. 10.1093\/annonc\/mdx323","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2011.02758.x","article-title":"Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review","volume":"13","author":"Bocale D","year":"2011","unstructured":"Bocale D, Rotelli MT, Cavallini A, Altomare DF. Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review. Colorectal Dis. 2011, 13:e388-95. 10.1111\/j.1463-1318.2011.02758.x","journal-title":"Colorectal Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-015-9830-z","article-title":"Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients","volume":"15","author":"Quast DR","year":"2016","unstructured":"Quast DR, Schneider R, Burdzik E, Hoppe S, M\u00f6slein G. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Fam Cancer. 2016, 15:31-40. 10.1007\/s10689-015-9830-z","journal-title":"Fam Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3197-x","article-title":"Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought","volume":"20","author":"Bonvalot S","year":"2013","unstructured":"Bonvalot S, Tern\u00e8s N, Fiore M, et al.. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol. 2013, 20:4096-102. 10.1245\/s10434-013-3197-x","journal-title":"Ann Surg Oncol"},{"key":"ref7","article-title":"Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options","volume":"4","author":"Santos GA","year":"2010","unstructured":"Santos GA, Cunha IW, Rocha RM, Mello CA, Guimar\u00e3es GC, Fregnani JH, Lopes A. Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. Biosci Trends. 2010, 4:25-30.","journal-title":"Biosci Trends"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.026278","article-title":"Immunohistochemical analysis of desmoid tumours","volume":"58","author":"Leithner A","year":"2005","unstructured":"Leithner A, Gapp M, Radl R, et al.. Immunohistochemical analysis of desmoid tumours. J Clin Pathol. 2005, 58:1152-6. 10.1136\/jcp.2005.026278","journal-title":"J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21553","article-title":"Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases","volume":"106","author":"Deyrup AT","year":"2006","unstructured":"Deyrup AT, Tretiakova M, Montag AG. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer. 2006, 106:208-13. 10.1002\/cncr.21553","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12037","article-title":"Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-\u03b2, COX2 and sex steroid receptors","volume":"103","author":"Mignemi NA","year":"2012","unstructured":"Mignemi NA, Itani DM, Fasig JH, et al.. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-\u03b2, COX2 and sex steroid receptors. Cancer Sci. 2012, 103:2173-80. 10.1111\/cas.12037","journal-title":"Cancer Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.210.189","article-title":"Expression profiles of sex steroid receptors in desmoid tumors","volume":"210","author":"Ishizuka M","year":"2006","unstructured":"Ishizuka M, Hatori M, Dohi O, et al.. Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med. 2006, 210:189-98. 10.1620\/tjem.210.189","journal-title":"Tohoku J Exp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25407","article-title":"Estrogen receptor beta expression correlates with proliferation in desmoid tumors","volume":"119","author":"Santti K","year":"2019","unstructured":"Santti K, Ihalainen H, R\u00f6nty M, et al.. Estrogen receptor beta expression correlates with proliferation in desmoid tumors. J Surg Oncol. 2019, 119:873-9. 10.1002\/jso.25407","journal-title":"J Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","year":"2020","unstructured":"The management of desmoid tumours. a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer. 2020, 127:96-107. 10.1016\/j.ejca.2019.11.013","journal-title":"Eur J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.017","article-title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group","volume":"83","author":"Penel N","year":"2017","unstructured":"Penel N, Le Cesne A, Bonvalot S, et al.. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group. Eur J Cancer. 2017, 83:125-31. 10.1016\/j.ejca.2017.06.017","journal-title":"Eur J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.05.002","article-title":"What is the best front-line approach in patients with desmoid fibromatosis? - a retrospective analysis from a reference center","volume":"47","author":"Sobczuk P","year":"2021","unstructured":"Sobczuk P, Agnieszczak IM, Grycuk W, et al.. What is the best front-line approach in patients with desmoid fibromatosis? - a retrospective analysis from a reference center. Eur J Surg Oncol. 2021, 47:2602-8. 10.1016\/j.ejso.2021.05.002","journal-title":"Eur J Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.11.019","article-title":"Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients","volume":"51","author":"Colombo C","year":"2015","unstructured":"Colombo C, Miceli R, Le P\u00e9choux C, et al.. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. Eur J Cancer. 2015, 51:186-92. 10.1016\/j.ejca.2014.11.019","journal-title":"Eur J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.08.026","article-title":"Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis","volume":"51","author":"Fiore M","year":"2015","unstructured":"Fiore M, Colombo C, Radaelli S, et al.. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis. Eur J Cancer. 2015, 51:2800-7. 10.1016\/j.ejca.2015.08.026","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder MM","year":"2018","unstructured":"Gounder MM, Mahoney MR, Van Tine BA, et al.. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med. 2018, 379:2417-28. 10.1056\/NEJMoa1805052","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30276-1","article-title":"Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study","volume":"20","author":"Toulmonde M","year":"2019","unstructured":"Toulmonde M, Pulido M, Ray-Coquard I, et al.. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncol. 2019, 20:1263-72. 10.1016\/S1470-2045(19)30276-1","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149853-complete-regression-of-an-8-cm-desmoid-fibromatosis-after-treatment-with-tamoxifen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:12Z","timestamp":1707508692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149853-complete-regression-of-an-8-cm-desmoid-fibromatosis-after-treatment-with-tamoxifen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.37431","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,11]]}}}